Skip to main content
SpringerLink
Log in

Scabies and Secondary Infections

  • Chapter
  • First Online:
Scabies

  • 208 Accesses

Abstract

Scabies infection may be complicated by secondary bacterial infections, most commonly due to Staphylococcus aureus and group A Streptococcus. Direct trauma from scratching and specific proteins secreted by the scabies mite predispose to proliferation of bacteria in the skin. The most common clinical manifestation of scabies-related bacterial skin infection is impetigo. Scabies infestation can also lead to more severe skin and soft tissue infections such as abscess, cellulitis and necrotising fasciitis, as well as invasive infections including sepsis and toxic shock syndrome. Further, scabies-related impetigo has been linked to secondary immune complications of group A streptococcal infection – acute post-streptococcal glomerulonephritis and possibly acute rheumatic fever. Secondary bacterial infectious complications are a significant contributor to the morbidity and mortality caused by scabies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, et al. Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis. 2013;7(8):e2167.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Karthikeyan G, Guilherme L. Acute rheumatic fever. Lancet. 2018;392(10142):161–74.

    Article  PubMed  Google Scholar 

  3. Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The public health control of scabies: priorities for research and action. Lancet. 2019;394(10192):81–92.

    Article  PubMed  Google Scholar 

  4. World Health Organization. Epidemiology and management of common skin diseases in children in developing countries. Geneva: World Health Organization; 2005.

    Google Scholar 

  5. Romani L, Steer AC, Whitfeld MJ, Kaldor JM. Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis. 2015;15(8):960–7.

    Article  PubMed  Google Scholar 

  6. Romani L, Koroivueta J, Steer AC, Kama M, Kaldor JM, Wand H, et al. Scabies and impetigo prevalence and risk factors in Fiji: a national survey. PLoS Negl Trop Dis. 2015;9(3):e0003452.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug administration for scabies control in a population with endemic disease. N Engl J Med. 2015;373(24):2305–13.

    Article  CAS  PubMed  Google Scholar 

  8. Mason DS, Marks M, Sokana O, Solomon AW, Mabey DC, Romani L, et al. The prevalence of scabies and impetigo in the Solomon Islands: a population-based survey. PLoS Negl Trop Dis. 2016;10(6):e0004803.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, et al. Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin. Clin Infect Dis. 2020;70(8):1591–5.

    Article  CAS  PubMed  Google Scholar 

  10. Mika A, Reynolds SL, Mohlin FC, Willis C, Swe PM, Pickering DA, et al. Novel scabies mite serpins inhibit the three pathways of the human complement system. PloS One. 2012;7(7):e40489.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bergstrom FC, Reynolds S, Johnstone M, Pike RN, Buckle AM, Kemp DJ, et al. Scabies mite inactivated serine protease paralogs inhibit the human complement system. J Immunol. 2009;182(12):7809–17.

    Article  PubMed  Google Scholar 

  12. Willis C, Fischer K, Walton SF, Currie BJ, Kemp DJ. Scabies mite inactivated serine protease paralogues are present both internally in the mite gut and externally in feces. Am J Trop Med Hyg. 2006;75(4):683–7.

    Article  CAS  PubMed  Google Scholar 

  13. Swe PM, Christian LD, Lu HC, Sriprakash KS, Fischer K. Complement inhibition by Sarcoptes scabiei protects Streptococcus pyogenes - an in vitro study to unravel the molecular mechanisms behind the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Negl Trop Dis. 2017;11(3):e0005437.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Swe PM, Fischer K. A scabies mite serpin interferes with complement-mediated neutrophil functions and promotes staphylococcal growth. PLoS Negl Trop Dis. 2014;8(6):e2928.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Swe PM, Zakrzewski M, Kelly A, Krause L, Fischer K. Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl Trop Dis. 2014;8(5):e2897.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Steer AC, Tikoduadua LV, Manalac EM, Colquhoun S, Carapetis JR, Maclennan C. Validation of an integrated management of childhood illness algorithm for managing common skin conditions in Fiji. Bull World Health Organ. 2009;87(3):173–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Steer AC, Jenney AW, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis. 2009;3(6):e467.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tasani M, Tong SY, Andrews RM, Holt DC, Currie BJ, Carapetis JR, et al. The importance of scabies coinfection in the treatment considerations for impetigo. Pediatr Infect Dis J. 2016;35(4):374–8.

    Article  PubMed  Google Scholar 

  20. Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. The epidemiology of scabies and impetigo in relation to demographic and residential characteristics: baseline findings from the Skin Health Intervention Fiji Trial. Am J Trop Med Hyg. 2017;97(3):845–50.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Aung PTZ, Cuningham W, Hwang K, Andrews RM, Carapetis JR, Kearns T, et al. Scabies and risk of skin sores in remote Australian Aboriginal communities: a self-controlled case series study. PLoS Negl Trop Dis. 2018;12(7):e0006668.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Korte LM, Bowen AC, Draper ADK, Davis K, Steel A, Teodora I, et al. Scabies and impetigo in Timor-Leste: a school screening study in two districts. PLoS Negl Trop Dis. 2018;12(5):e0006400.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Armitage EP, Senghore E, Darboe S, Barry M, Camara J, Bah S, et al. High burden and seasonal variation of paediatric scabies and pyoderma prevalence in The Gambia: a cross-sectional study. PLoS Negl Trop Dis. 2019;13(10):e0007801.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Marks M, Sammut T, Cabral MG, Teixeira da Silva E, Goncalves A, Rodrigues A, et al. The prevalence of scabies, pyoderma and other communicable dermatoses in the Bijagos Archipelago, Guinea-Bissau. PLoS Negl Trop Dis. 2019;13(11):e0007820.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Osti MH, Sokana O, Phelan S, Marks M, Whitfeld MJ, Gorae C, et al. Prevalence of scabies and impetigo in the Solomon Islands: a school survey. BMC Infect Dis. 2019;19(1):803.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Davidson L, Knight J, Bowen AC. Skin infections in Australian Aboriginal children: a narrative review. Med J Aust. 2020;212(5):231–7.

    Article  PubMed  Google Scholar 

  27. Ghimire RB, Pokharel K, Shrestha S. Prevalence of community-acquired pyoderma in Dermatological Outpatient Department of a Tertiary Care Hospital. JNMA J Nepal Med Assoc. 2019;57(217):159–63.

    PubMed  PubMed Central  Google Scholar 

  28. Bommakanti J, Pendyala P. Pattern of skin diseases in rural population: a cross sectional study at Medchal mandal, Rangareddy district, Telangana, India. Int J Res Med Sci. 2017;5(1): 50–5. https://doi.org/10.18203/2320-6012.ijrms20164443.

  29. Grills N, Grills C, Spelman T, Stoove M, Hellard M, El-Hayek C, et al. Prevalence survey of dermatological conditions in mountainous north India. Int J Dermatol. 2012;51(5):579–87.

    Article  PubMed  Google Scholar 

  30. Satimia FT, McBride SR, Leppard B. Prevalence of skin disease in rural Tanzania and factors influencing the choice of health care, modern or traditional. Arch Dermatol. 1998;134(11):1363–6.

    Article  CAS  PubMed  Google Scholar 

  31. Henderson CA. Skin disease in rural Tanzania. Int J Dermatol. 1996;35(9):640–2.

    Article  CAS  PubMed  Google Scholar 

  32. Hegazy AA, Darwish NM, Abdel-Hamid IA, Hammad SM. Epidemiology and control of scabies in an Egyptian village. Int J Dermatol. 1999;38(4):291–5.

    Article  CAS  PubMed  Google Scholar 

  33. El-Akhras A, Sonbol O, Khattab M. Prevalence of skin diseases in rural area. N Egypt J Med. 1992;6:844–9.

    Google Scholar 

  34. Bissek AC, Tabah EN, Kouotou E, Sini V, Yepnjio FN, Nditanchou R, et al. The spectrum of skin diseases in a rural setting in Cameroon (sub-Saharan Africa). BMC Dermatol. 2012;12:7.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Al-Rubiay K, Al-Rubaiy L. Dermatoepidemiology: a household survey among two urban areas in Basrah City, Iraq. Internet J Dermatol. 2015;4(2):8.

    Google Scholar 

  36. Al Samarai AG. Prevalence of skin diseases in Iraq: a community based study. Int J Dermatol. 2009;48(7):734–9.

    Article  PubMed  Google Scholar 

  37. Feldmeier H, Jackson A, Ariza L, Calheiros CM, Soares Vde L, Oliveira FA, et al. The epidemiology of scabies in an impoverished community in rural Brazil: presence and severity of disease are associated with poor living conditions and illiteracy. J Am Acad Dermatol. 2009;60(3):436–43.

    Article  PubMed  Google Scholar 

  38. Heukelbach J, Wilcke T, Winter B, Feldmeier H. Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil. Br J Dermatol. 2005;153(1):150–6.

    Article  CAS  PubMed  Google Scholar 

  39. Jackson A, Heukelbach J, Filho AF, Junior Ede B, Feldmeier H. Clinical features and associated morbidity of scabies in a rural community in Alagoas, Brazil. Trop Med Int Health. 2007;12(4):493–502.

    Article  PubMed  Google Scholar 

  40. Massa A, Alves R, Amado J, Matos E, Sanches M, Selores M, et al. Prevalence of cutaneous lesions in Freixo de Espada à Cinta. Acta Med Port. 2000;13(5-6):247–54.

    CAS  PubMed  Google Scholar 

  41. Koning S, van der Sande R, Verhagen AP, van Suijlekom-Smit LW, Morris AD, Butler CC, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1(1):Cd003261.

    PubMed  Google Scholar 

  42. Yeoh DK, Bowen AC, Carapetis JR. Impetigo and scabies - disease burden and modern treatment strategies. J Infect. 2016;72(Suppl):S61–7.

    Article  PubMed  Google Scholar 

  43. National Institute for Health and Care Excellence. Impetigo: antimicrobial prescribing [Guideline]. London: NICE; 2020 [updated 26 February 2020]. https://www.nice.org.uk/guidance/ng153/resources/impetigo-antimicrobial-prescribing-pdf-66141838603717.

  44. Herchlien TE, Swaminathan S, Chandrasekar PH. What are the IDSA guidelines on the treatment of impetigo in children? Medscape; 2019 [updated 14 June 2019]. https://www.medscape.com/answers/214222-3144/what-are-the-idsa-guidelines-on-the-treatment-of-impetigo-in-children.

  45. Impetigo. eTG complete [digital]. Melbourne: Therapeutic Guidelines Limited; 2019. https://www.tg.org.au.

  46. The Australian Healthy Skin Consortium. National Healthy Skin Guideline: for the Prevention, Treatment and Public Health Control of Impetigo, Scabies, Crusted Scabies and Tinea for Indigenous Populations and Communities in Australia (1st edition): Telethon Kids Institute; 2018. https://infectiousdiseases.telethonkids.org.au/siteassets/media-docs%2D%2D-wesfarmers-centre/national-healthy-skin-guideline%2D%2D-1st-ed.-2018.pdf.

  47. Tong SY, Andrews RM, Kearns T, Gundjirryirr R, McDonald MI, Currie BJ, et al. Trimethopim-sulfamethoxazole compared with benzathine penicillin for treatment of impetigo in Aboriginal children: a pilot randomised controlled trial. J Paediatr Child Health. 2010;46(3):131–3.

    Article  PubMed  Google Scholar 

  48. Bowen AC, Tong SY, Andrews RM, O’Meara IM, McDonald MI, Chatfield MD, et al. Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: an open-label, randomised, controlled, non-inferiority trial. Lancet. 2014;384(9960):2132–40.

    Article  CAS  PubMed  Google Scholar 

  49. May PJ, Tong SYC, Steer AC, Currie BJ, Andrews RM, Carapetis JR, et al. Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review. Trop Med Int Health. 2019;24(3):280–93.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Koning S, Verhagen AP, van Suijlekom-Smit LW, Morris A, Butler CC, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev. 2004;(2):CD003261.

    Google Scholar 

  51. Bowen AC, Lilliebridge RA, Tong SY, Baird RW, Ward P, McDonald MI, et al. Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? J Clin Microbiol. 2012;50(12):4067–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Miller LG, Daum RS, Creech CB, Young D, Downing MD, Eells SJ, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med. 2015;372(12):1093–103.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Carapetis JR, Connors C, Yarmirr D, Krause V, Currie BJ. Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J. 1997;16(5):494–9.

    Article  CAS  PubMed  Google Scholar 

  54. Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, et al. Mass drug administration for scabies - 2 years of follow-up. N Engl J Med. 2019;381(2):186–7.

    Article  PubMed  Google Scholar 

  55. Marks M, Taotao-Wini B, Satorara L, Engelman D, Nasi T, Mabey DC, et al. Long term control of scabies fifteen years after an intensive treatment programme. PLoS Negl Trop Dis. 2015;9(12):e0004246.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Cordell B, et al. Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial. Lancet Infect Dis. 2019;19(5):510–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Marks M, Toloka H, Baker C, Kositz C, Asugeni J, Puiahi E, et al. Randomized trial of community treatment with azithromycin and ivermectin mass drug administration for control of scabies and impetigo. Clin Infect Dis. 2019;68(6):927–33.

    Article  CAS  PubMed  Google Scholar 

  58. Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, et al. Global skin disease morbidity and mortality: an update from the Global Burden of Disease Study 2013. JAMA Dermatol. 2017;153(5):406–12.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Miller LG, Eisenberg DF, Liu H, Chang CL, Wang Y, Luthra R, et al. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010. BMC Infect Dis. 2015;15:362.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Harch SAJ, MacMorran E, Tong SYC, Holt DC, Wilson J, Athan E, et al. High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA. BMC Infect Dis. 2017;17(1):405.

    Article  PubMed  PubMed Central  Google Scholar 

  61. O’Sullivan CE, Baker MG, Zhang J. Increasing hospitalizations for serious skin infections in New Zealand children, 1990-2007. Epidemiol Infect. 2011;139(11):1794–804.

    Article  PubMed  Google Scholar 

  62. Azizpour A, Nasimi M, Ghanadan A, Mohammadi F, Shakoei S. Crusted scabies complicated with herpes simplex and sepsis. Indian J Dermatol. 2020;65(4):304–6.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Bonazzetti C, Pagani G, Giacomelli A, Morena V, Bassoli C, Corbellino M, et al. A case of crusted scabies with a delayed diagnosis and inadequate therapy. Infez Med. 2020;28(3):436–40.

    PubMed  Google Scholar 

  64. Steer AC, Lamagni T, Curtis N, Carapetis JR. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012;72(9):1213–27.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Nelson GE, Pondo T, Toews KA, Farley MM, Lindegren ML, Lynfield R, et al. Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012. Clin Infect Dis. 2016;63(4):478–86.

    Article  PubMed  Google Scholar 

  66. Dayan GH, Mohamed N, Scully IL, Cooper D, Begier E, Eiden J, et al. Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention. Expert Rev Vaccines. 2016;15(11):1373–92.

    Article  CAS  PubMed  Google Scholar 

  67. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94.

    Article  PubMed  Google Scholar 

  68. Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect. 2013;19(6):492–500.

    Article  CAS  PubMed  Google Scholar 

  69. Tong SY, van Hal SJ, Einsiedel L, Currie BJ, Turnidge JD. Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians. BMC Infect Dis. 2012;12:249.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Jenney A, Holt D, Ritika R, Southwell P, Pravin S, Buadromo E, et al. The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji. BMC Infect Dis. 2014;14:160.

    Article  PubMed  PubMed Central  Google Scholar 

  71. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25(2):362–86.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Hewagama S, Spelman T, Einsiedel LJ. Staphylococcus aureus bacteraemia at Alice Springs Hospital, Central Australia, 2003-2006. Intern Med J. 2012;42(5):505–12.

    Article  CAS  PubMed  Google Scholar 

  73. Skull SA, Krause V, Coombs G, Pearman JW, Roberts LA. Investigation of a cluster of Staphylococcus aureus invasive infection in the top end of the Northern Territory. Aust N Z J Med. 1999;29(1):66–72.

    Article  CAS  PubMed  Google Scholar 

  74. Engelman D, Hofer A, Davis JS, Carapetis JR, Baird RW, Giffard PM, et al. Invasive Staphylococcus aureus infections in children in tropical Northern Australia. J Pediatr Infect Dis Soc. 2014;3(4):304–11.

    Article  Google Scholar 

  75. Ferretti JJ, Stevens DL, Fischetti VA. Streptococcus pyogenes: basic biology to clinical manifestations. Oklahoma City: University of Oklahoma Health Sciences Center; 2016. https://www.ncbi.nlm.nih.gov/books/NBK333424/.

    Google Scholar 

  76. Steer AC, Jenney A, Kado J, Good MF, Batzloff M, Waqatakirewa L, et al. Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007. Emerg Infect Dis. 2009;15(2):216–22.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Wang MK, Chin-Yee B, Lo CK, Lee S, El-Helou P, Alowami S, et al. Crusted scabies in a renal transplant recipient treated with daily ivermectin: a case report and literature review. Transpl Infect Dis. 2019;21(3):e13077.

    Article  PubMed  Google Scholar 

  78. Lin S, Farber J, Lado L. A case report of crusted scabies with methicillin-resistant Staphylococcus aureus bacteremia. J Am Geriatr Soc. 2009;57(9):1713–4.

    Article  PubMed  Google Scholar 

  79. Skinner SM, DeVillez RL. Sepsis associated with Norwegian scabies in patients with acquired immunodeficiency syndrome. Cutis. 1992;50(3):213–6.

    CAS  PubMed  Google Scholar 

  80. Subramaniam G, Kaliaperumal K, Duraipandian J, Rengasamy G. Norwegian scabies in a malnourished young adult: a case report. J Infect Dev Ctries. 2010;4(5):349–51.

    Article  PubMed  Google Scholar 

  81. Glover A, Young L, Goltz AW. Norwegian scabies in acquired immunodeficiency syndrome: report of a case resulting in death from associated sepsis. J Am Acad Dermatol. 1987;16(2 Pt 1):396–9.

    Article  CAS  PubMed  Google Scholar 

  82. Mansy H, Somorin A, el-Sherif M, Eze C, al-Dusari S, Filobbos P. Norwegian scabies complicated by fatal brain abscess in a renal transplant patient. Nephron. 1996;72(2):323–4.

    Article  CAS  PubMed  Google Scholar 

  83. Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect. 2005;50(5):375–81.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Tropical Diseases, Murdoch Children’s Research Institute, Melbourne, VIC, Australia

    Shu Ki Tsoi, Li Jun Thean, Andrew C. Steer & Daniel Engelman

  2. Melbourne Children’s Global Health, Melbourne, VIC, Australia

    Li Jun Thean, Andrew C. Steer & Daniel Engelman

  3. Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia

    Andrew C. Steer & Daniel Engelman

  4. General Medicine, Royal Children’s Hospital, Melbourne, Australia

    Daniel Engelman

Authors
  1. Shu Ki Tsoi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li Jun Thean
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew C. Steer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel Engelman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniel Engelman .

Editor information

Editors and Affiliations

  1. QIMR Berghofer Medical Research Institut, Herston, QLD, Australia

    Katja Fischer

  2. UPE-Université Paris-Est, Service de Dermatologie, Hôpital Henri Mondor, EA 7379 EpiDermE et INSERM CIC 1430, Créteil, France

    Olivier Chosidow

Rights and permissions

Reprints and permissions

Copyright information

© 2023 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tsoi, S.K., Thean, L.J., Steer, A.C., Engelman, D. (2023). Scabies and Secondary Infections. In: Fischer, K., Chosidow, O. (eds) Scabies. Springer, Cham. https://doi.org/10.1007/978-3-031-26070-4_11

Download citation

Publish with us

Policies and ethics

Search

Navigation